ID: uc002uxj.1_intron_7_0_chr2_202072907_f.5p
GENE: CASP10(8)
chr2:202072857-202073106+


(3)
B-CELL
(1)
BRAIN
(1)
BREAST
(14)
CELL-LINE
(1)
HELA
(4)
LIVER
(2)
OTHER
(15)
SKIN
(1)
TESTES
(1)
XRN.ip

Sense strand
CCACAGCTTTACCTCCCTGAAGGACAGACAAGGAACCCATAAAGATGCTGGTAAGAAAGTCTGGAACAGTTTATCAAATGCAAATTGGGGATCTTAAAATTATTTTTTATTTTCACATTTTCTTTCTGTGACTTTTATCTTCCATATACGTGTAAGGATGATATCATGTTTCTGAGCCTCTTATATATCCCTGGGGAGTCATCAGTCTGCTAAAGAGTGGCAAGAATCTTTGACTATTCACAATTCTGAA
....................................................((((((((.((((.((((((.........)))))).......(((((.....)))))..)))).))))))))..............................................................................................................................
..................................................51...............................................................................132....................................................................................................................
SizePerfect hitTotal NormPerfect NormSRR207116(GSM721078)
Nuclear RNA. (cell line)
DRR001489(DRX001043)
"Hela short nuclear cell fraction, control". (hela)
SRR330868(SRX091706)
tissue: skin psoriatic involveddisease state:. (skin)
SRR330865(SRX091703)
tissue: skin psoriatic involveddisease state:. (skin)
DRR000556(DRX000314)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)
DRR000558(DRX000316)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)
SRR039622(GSM531985)
HCV(+) Adjacent Tissue Sample. (liver)
SRR037942(GSM510480)
293DroshaTN_cand5. (cell line)
SRR330880(SRX091718)
tissue: skin psoriatic involveddisease state:. (skin)
SRR189781(GSM714641)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR189782GSM359208(GSM359208)
hepg2_bindASP_hl_2. (cell line)
SRR330889(SRX091727)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR330872(SRX091710)
tissue: skin psoriatic involveddisease state:. (skin)
SRR330879(SRX091717)
tissue: skin psoriatic involveddisease state:. (skin)
SRR039625(GSM531988)
HBV(-) HCV(-) HCC Tissue Sample. (liver)
SRR039620(GSM531983)
HBV(+) Adjacent Tissue Sample 2. (liver)
SRR189787GSM450601(GSM450601)
miRNA sequencing raw reads from post-mortem s. (brain)
SRR330863(SRX091701)
tissue: skin psoriatic involveddisease state:. (skin)
SRR033717(GSM497062)
Mentle Cell Lymphoma (MCL112). (B cell)
SRR330891(SRX091729)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR330864(SRX091702)
tissue: skin psoriatic involveddisease state:. (skin)
SRR060984(GSM569188)
Human plasma cell [09-001]. (cell line)
TAX577740(Rovira)
total RNA. (breast)
SRR015364(GSM380329)
Plasma B cells (PC44). (B cell)
SRR039192(GSM494811)
K562 cell line is derived from a CML patient . (cell line)
SRR189780(GSM714640)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR330861(SRX091699)
tissue: skin psoriatic involveddisease state:. (skin)
SRR330919(SRX091757)
tissue: normal skindisease state: normal. (skin)
SRR039635(GSM518472)
THP1_nuc_sRNAs. (cell line)
SRR207115(GSM721077)
XRN1&2 knockdown. (XRN1/XRN2 cell line)
SRR553576(SRX182782)
source: Testis. (testes)
SRR038857(GSM458540)
D20. (cell line)
SRR330894(SRX091732)
tissue: skin psoriatic uninvolveddisease stat. (skin)
GSM359191(GSM359191)
HepG2_3pM_5. (cell line)
SRR060986(GSM569190)
Human memory B cell [09-001]. (cell line)
SRR330866(SRX091704)
tissue: skin psoriatic involveddisease state:. (skin)
SRR330878(SRX091716)
tissue: skin psoriatic involveddisease state:. (skin)
SRR039623(GSM531986)
HCV(+) HCC Tissue Sample. (liver)
SRR330859(SRX091697)
tissue: skin psoriatic involveddisease state:. (skin)
SRR033721(GSM497066)
Ly3 cell line (Ly3). (B cell)
......................................................................................................................................................TGTAAGGATGATATCATGTTTCTGAGC.........................................................................27144.0044.008.004.004.003.003.003.00-2.002.00--1.001.001.00-----1.001.001.001.001.00----1.00--1.00-1.001.00--1.001.00-1.00-
.......................................................................................................................................................GTAAGGATGATATCATGTTTCTGAGC.........................................................................2613.003.003.00-----------------------------------------
.............TCCCTGAAGGACAGACAAGG.........................................................................................................................................................................................................................2012.002.00------1.00--------------------------------1.00--
............................................................................................................ATTTTCACATTTTCTTTTTA..........................................................................................................................201.000.00---------------------------1.00--------------
.............................AAGGAACCCATAAAGATGCTG........................................................................................................................................................................................................2111.001.00------------------------------1.00-----------
.................................................................................................AATTATTTTTTATTTTCGGG.....................................................................................................................................201.000.00---------1.00--------------------------------
......................GACAGACAAGGAACCCATAAAGATGCTG........................................................................................................................................................................................................2811.001.00-------------------------1.00----------------
............CTCCCTGAAGGACAGACA............................................................................................................................................................................................................................1811.001.00------------------1.00-----------------------
...................................................................................................................................................................................................................AAAGAGTGGCAAGAATCTTTGAC................2311.001.00------1.00-----------------------------------
..................GAAGGACAGACAAGGAACCCATAAAGATA...........................................................................................................................................................................................................291.000.00------1.00-----------------------------------
..........................GACAAGGAACCCATAAAGATGCTGAGAT....................................................................................................................................................................................................281.000.00--------------------------1.00---------------
...................AAGGACAGACAAGGAACCCATAAAGATGC..........................................................................................................................................................................................................2911.001.00--------------------------------1.00---------
............................................ATGCTGGTAAGAAAGTCTGGAACAGTT...................................................................................................................................................................................2711.001.00-----------------------------1.00------------
......................................................GAAAGTCTGGAACAGTGGTA................................................................................................................................................................................201.000.00----------1.00-------------------------------
........................CAGACAAGGAACCCATAAAGATGCTG........................................................................................................................................................................................................2611.001.00----------------1.00-------------------------
......................................................................................................................................................TGTAAGGATGATATCATGTTTCTGAG..........................................................................2611.001.00-----------------------------------1.00------
......................................................................................................................................................TGTAAGGATGATATCATGTTTCT.............................................................................2311.001.00---------------1.00--------------------------
.....................................................................................................ATTTTTTATTTTCACGGGC..................................................................................................................................191.000.00-----------------1.00------------------------
...............CCTGAAGGACAGACAAGGAACCCATAAAGA.............................................................................................................................................................................................................3011.001.00--------------1.00---------------------------
..................................................GTAAGAAAGTCTGGAACAGTTTA.................................................................................................................................................................................2311.001.00------------------------------------1.00-----
.................TGAAGGACAGACAAGGAA.......................................................................................................................................................................................................................1820.500.50-----------------------------------------0.50
...............................................................................................................TTCACATTTTCTTTCTG..........................................................................................................................1720.500.50----------0.50-------------------------------

Antisense strand
CCACAGCTTTACCTCCCTGAAGGACAGACAAGGAACCCATAAAGATGCTGGTAAGAAAGTCTGGAACAGTTTATCAAATGCAAATTGGGGATCTTAAAATTATTTTTTATTTTCACATTTTCTTTCTGTGACTTTTATCTTCCATATACGTGTAAGGATGATATCATGTTTCTGAGCCTCTTATATATCCCTGGGGAGTCATCAGTCTGCTAAAGAGTGGCAAGAATCTTTGACTATTCACAATTCTGAA
....................................................((((((((.((((.((((((.........)))))).......(((((.....)))))..)))).))))))))..............................................................................................................................
..................................................51...............................................................................132....................................................................................................................
SizePerfect hitTotal NormPerfect NormSRR207116(GSM721078)
Nuclear RNA. (cell line)
DRR001489(DRX001043)
"Hela short nuclear cell fraction, control". (hela)
SRR330868(SRX091706)
tissue: skin psoriatic involveddisease state:. (skin)
SRR330865(SRX091703)
tissue: skin psoriatic involveddisease state:. (skin)
DRR000556(DRX000314)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)
DRR000558(DRX000316)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)
SRR039622(GSM531985)
HCV(+) Adjacent Tissue Sample. (liver)
SRR037942(GSM510480)
293DroshaTN_cand5. (cell line)
SRR330880(SRX091718)
tissue: skin psoriatic involveddisease state:. (skin)
SRR189781(GSM714641)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR189782GSM359208(GSM359208)
hepg2_bindASP_hl_2. (cell line)
SRR330889(SRX091727)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR330872(SRX091710)
tissue: skin psoriatic involveddisease state:. (skin)
SRR330879(SRX091717)
tissue: skin psoriatic involveddisease state:. (skin)
SRR039625(GSM531988)
HBV(-) HCV(-) HCC Tissue Sample. (liver)
SRR039620(GSM531983)
HBV(+) Adjacent Tissue Sample 2. (liver)
SRR189787GSM450601(GSM450601)
miRNA sequencing raw reads from post-mortem s. (brain)
SRR330863(SRX091701)
tissue: skin psoriatic involveddisease state:. (skin)
SRR033717(GSM497062)
Mentle Cell Lymphoma (MCL112). (B cell)
SRR330891(SRX091729)
tissue: skin psoriatic uninvolveddisease stat. (skin)
SRR330864(SRX091702)
tissue: skin psoriatic involveddisease state:. (skin)
SRR060984(GSM569188)
Human plasma cell [09-001]. (cell line)
TAX577740(Rovira)
total RNA. (breast)
SRR015364(GSM380329)
Plasma B cells (PC44). (B cell)
SRR039192(GSM494811)
K562 cell line is derived from a CML patient . (cell line)
SRR189780(GSM714640)
cell line: HEK293clip variant: PAR-CLIPenzyma. (cell line)
SRR330861(SRX091699)
tissue: skin psoriatic involveddisease state:. (skin)
SRR330919(SRX091757)
tissue: normal skindisease state: normal. (skin)
SRR039635(GSM518472)
THP1_nuc_sRNAs. (cell line)
SRR207115(GSM721077)
XRN1&2 knockdown. (XRN1/XRN2 cell line)
SRR553576(SRX182782)
source: Testis. (testes)
SRR038857(GSM458540)
D20. (cell line)
SRR330894(SRX091732)
tissue: skin psoriatic uninvolveddisease stat. (skin)
GSM359191(GSM359191)
HepG2_3pM_5. (cell line)
SRR060986(GSM569190)
Human memory B cell [09-001]. (cell line)
SRR330866(SRX091704)
tissue: skin psoriatic involveddisease state:. (skin)
SRR330878(SRX091716)
tissue: skin psoriatic involveddisease state:. (skin)
SRR039623(GSM531986)
HCV(+) HCC Tissue Sample. (liver)
SRR330859(SRX091697)
tissue: skin psoriatic involveddisease state:. (skin)
SRR033721(GSM497066)
Ly3 cell line (Ly3). (B cell)
.......................................................................................................................................................................................................CATCAGTCTGCTAAATTGA................................ 191.000.00------------------------1.00-----------------
.......................................................AAAGTCTGGAACAGTTGT................................................................................................................................................................................. 181.000.00---------1.00--------------------------------